4th Drug Discovery for Neurodegeneration
February 1-2, 2010, Houston, TX
The purpose of the conference is to advance drug discovery for neurodegenerative disease by educating academic scientists on the processes of translating basic research into novel therapies. The didactic conference will give participants knowledge and relevant resources about this field of scientific investigation and address the associated barriers and challenges. Speakers and chairs will present lectures and case studies on Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, Multiple Sclerosis and other ‘orphan’ neurodegenerative diseases. Ample time for questions and networking is also integrated into the program. The meeting attracts approximately 200 participants from around the world.
For more information and to register, click here.